Pharmacokinetics of the Brimonidine Tartrate Posterior Segment Delivery System in Patients Undergoing Pars Plana Vitrectomy

NCT01229410 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Vitrectomy

Interventions

DRUG: 400 µg Brimonidine Tartrate Implant
DRUG: 200 µg Brimonidine Tartrate Implant

Sponsor

Allergan